Search

Your search keyword '"Rossi, Davide"' showing total 188 results

Search Constraints

Start Over You searched for: Author "Rossi, Davide" Remove constraint Author: "Rossi, Davide" Publisher elsevier inc. Remove constraint Publisher: elsevier inc.
188 results on '"Rossi, Davide"'

Search Results

3. SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma

4. Genetic and phenotypic attributes of splenic marginal zone lymphoma

5. Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab

7. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

8. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1

9. Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial

10. Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models

11. HL-370 Fragmentóme Profiling Reveals Distinct Molecular Subgroups of Classic Hodgkin Lymphoma

13. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

16. The genetics of nodal marginal zone lymphoma

18. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

21. DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features

25. Genomic profiling for clinical decision making in lymphoid neoplasms

26. Clonal Evolution of Chronic Lymphocytic Leukemia with Bimodal CD49d Expression Reveals CD49d Plasticity

27. A Comprehensive DNA Methylome Analysis of Stereotyped and Non-Stereotyped CLL Reveals an Epigenetic Signature with Strong Clinical Impact Encompassing IGHV Status, Stereotypes and IGLV3-21R110

28. Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study

29. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

30. Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia

31. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

32. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

33. The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma

34. Efficacy and safety of once-weekly bortezomib in multiple myeloma patients

35. Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia

36. First-Line Venetoclax Combinations in Fit Patients with CLL: 4-Year Follow-up and NGS-Based MRD Analysis from the Phase 3 GAIA/CLL13 Trial

44. The CXCR4dim/CD5bright Proliferative Fraction Reappears in Relapsed CLL Under Ibrutinib, Enriched in BTK Mutations

46. Molecular Clustering on Ctdna May Improve Prognostic Stratification of DLBCL Patients

47. Viral cfDNA Profiling Reveals Distinct EBV Subtypes and Stratifies Risk in Hodgkin Lymphomas

48. Distinct Molecular Subtypes of Classic Hodgkin Lymphoma Identified By Comprehensive Noninvasive Profiling

Catalog

Books, media, physical & digital resources